OnabotulinumtoxinA from lines to facial reshaping: A new Italian consensus report.

Massimo SignoriniSalvatore Piero FundaròDario BertossiMaurizio CavalliniPierfrancesco CirilloGuglielmo NatuzziSandro QuartucciChantal SciutoMariagrazia PatalanoGloria Trocchi

Published in: Journal of cosmetic dermatology (2022)

Optimal practice with onabotulinumtoxinA requires a systematic approach to maximize safety and effectiveness across the range of potential uses. The present consensus was developed to support these aims.

Keyphrases

clinical practice
randomized controlled trial
primary care
healthcare
systematic review
quality improvement
soft tissue
risk assessment